Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Is fluorescein-guided technique able to help in resection of high-grade gliomas?
Acerbi F, Broggi M, Eoli M, Anghileri E, Cavallo C, Boffano C, Cordella R, Cuppini L, Pollo B, Schiariti M, Visintini S, Orsi C, La Corte E, Broggi G, Ferroli P. Acerbi F, et al. Among authors: anghileri e. Neurosurg Focus. 2014 Feb;36(2):E5. doi: 10.3171/2013.11.FOCUS13487. Neurosurg Focus. 2014. PMID: 24484258 Free article. Clinical Trial.
FABP4 is a candidate marker of cerebellar liponeurocytomas.
Anghileri E, Eoli M, Paterra R, Ferroli P, Pollo B, Cuccarini V, Maderna E, Tringali G, Saini M, Salsano E, Finocchiaro G. Anghileri E, et al. J Neurooncol. 2012 Jul;108(3):513-9. doi: 10.1007/s11060-012-0853-0. Epub 2012 Apr 3. J Neurooncol. 2012. PMID: 22476608
The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates.
Pellegatta S, Eoli M, Frigerio S, Antozzi C, Bruzzone MG, Cantini G, Nava S, Anghileri E, Cuppini L, Cuccarini V, Ciusani E, Dossena M, Pollo B, Mantegazza R, Parati EA, Finocchiaro G. Pellegatta S, et al. Among authors: anghileri e. Oncoimmunology. 2013 Mar 1;2(3):e23401. doi: 10.4161/onci.23401. Oncoimmunology. 2013. PMID: 23802079 Free PMC article.
Prognostic value of CD109+ circulating endothelial cells in recurrent glioblastomas treated with bevacizumab and irinotecan.
Cuppini L, Calleri A, Bruzzone MG, Prodi E, Anghileri E, Pellegatta S, Mancuso P, Porrati P, Di Stefano AL, Ceroni M, Bertolini F, Finocchiaro G, Eoli M. Cuppini L, et al. Among authors: anghileri e. PLoS One. 2013 Sep 12;8(9):e74345. doi: 10.1371/journal.pone.0074345. eCollection 2013. PLoS One. 2013. PMID: 24069296 Free PMC article.
Fluorescein-guided surgery for malignant gliomas: a review.
Acerbi F, Cavallo C, Broggi M, Cordella R, Anghileri E, Eoli M, Schiariti M, Broggi G, Ferroli P. Acerbi F, et al. Among authors: anghileri e. Neurosurg Rev. 2014 Oct;37(4):547-57. doi: 10.1007/s10143-014-0546-6. Epub 2014 Apr 23. Neurosurg Rev. 2014. PMID: 24756415 Review.
Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology).
Lombardi G, Pace A, Pasqualetti F, Rizzato S, Faedi M, Anghileri E, Nicolotto E, Bazzoli E, Bellu L, Villani V, Fabi A, Ferrazza P, Gurrieri L, Dall'Agata M, Eoli M, Della Puppa A, Pambuku A, D'Avella D, Berti F, Rudà R, Zagonel V. Lombardi G, et al. Among authors: anghileri e. J Neurooncol. 2015 Nov;125(2):359-67. doi: 10.1007/s11060-015-1923-x. Epub 2015 Sep 30. J Neurooncol. 2015. PMID: 26423801
51 results